Clinical Trial Update: High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 [Phase 4]

View source ↗

Summary

This Phase 4 trial compares high-dose versus standard-dose ribavirin in patients with chronic hepatitis C genotype 3. The study has completed and results were u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Ribavirin (ribavirin)

Snippet

Sponsor: Dr. Conrado Fernandez | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED